Dysmotility Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

Rifaximin's Effect on Covert Hepatic Encephalopathy in Cirrhosis Patients With Small Intestinal Bacterial Overgrowth and Gastrointestinal Dysmotility
Conditions:   Cirrhosis, Liver;   Minimal Hepatic Encephalopathy;   Small Intestinal Bacterial Overgrowth;   Gastrointestinal Motility Disorder Intervention:   Drug: Rifaximin Sponsor:   Ronnie Fass, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2020 Category: Research Source Type: clinical trials

Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit
Condition:   Cystic Fibrosis Gastrointestinal Disease Interventions:   Drug: Polyethylene Glycol 3350;   Device: SmartPill Motility System& PillCam Patency Capsule Sponsor:   St. Louis University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2019 Category: Research Source Type: clinical trials